145 related articles for article (PubMed ID: 2208159)
1. Action of gossypol and rhodamine 123 on wild type and multidrug-resistant MCF-7 human breast cancer cells: 31P nuclear magnetic resonance and toxicity studies.
Jaroszewski JW; Kaplan O; Cohen JS
Cancer Res; 1990 Nov; 50(21):6936-43. PubMed ID: 2208159
[TBL] [Abstract][Full Text] [Related]
2. Quantitative differential effects of rhodamine 123 on normal cells and human colon cancer cells by magnetic resonance spectroscopy.
Singer S; Neuringer LJ; Thilly WG; Chen LB
Cancer Res; 1993 Dec; 53(23):5808-14. PubMed ID: 8242640
[TBL] [Abstract][Full Text] [Related]
3. The multidrug resistance phenotype: 31P nuclear magnetic resonance characterization and 2-deoxyglucose toxicity.
Kaplan O; Jaroszewski JW; Clarke R; Fairchild CR; Schoenlein P; Goldenberg S; Gottesman MM; Cohen JS
Cancer Res; 1991 Mar; 51(6):1638-44. PubMed ID: 1998955
[TBL] [Abstract][Full Text] [Related]
4. Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy.
Lyon RC; Cohen JS; Faustino PJ; Megnin F; Myers CE
Cancer Res; 1988 Feb; 48(4):870-7. PubMed ID: 3338082
[TBL] [Abstract][Full Text] [Related]
5. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
6. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance.
Politi PM; Sinha BK
Mol Pharmacol; 1989 Mar; 35(3):271-8. PubMed ID: 2564628
[TBL] [Abstract][Full Text] [Related]
7. Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism.
Kaplan O; Navon G; Lyon RC; Faustino PJ; Straka EJ; Cohen JS
Cancer Res; 1990 Feb; 50(3):544-51. PubMed ID: 2297696
[TBL] [Abstract][Full Text] [Related]
8. Lactic dehydrogenase isozymes, 31P magnetic resonance spectroscopy, and in vitro antimitochondrial tumor toxicity with gossypol and rhodamine-123.
Benz C; Hollander C; Keniry M; James TL; Mitchell M
J Clin Invest; 1987 Feb; 79(2):517-23. PubMed ID: 3805280
[TBL] [Abstract][Full Text] [Related]
9. Liposome composition is important for retention of liposomal rhodamine in P-glycoprotein-overexpressing cancer cells.
Kang DI; Kang HK; Gwak HS; Han HK; Lim SJ
Drug Deliv; 2009 Jul; 16(5):261-7. PubMed ID: 19538007
[TBL] [Abstract][Full Text] [Related]
10. Effect of gossypol on cultured TM3 Leydig and TM4 Sertoli cells: 31P and 23Na NMR study.
Hansen LL; Jaroszewski JW
NMR Biomed; 1996 Apr; 9(2):72-8. PubMed ID: 8887371
[TBL] [Abstract][Full Text] [Related]
11. Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: a 31P-magnetic resonance spectroscopy study.
Sterin M; Cohen JS; Mardor Y; Berman E; Ringel I
Cancer Res; 2001 Oct; 61(20):7536-43. PubMed ID: 11606391
[TBL] [Abstract][Full Text] [Related]
12. Biochemical correlates of the antitumor and antimitochondrial properties of gossypol enantiomers.
Benz CC; Keniry MA; Ford JM; Townsend AJ; Cox FW; Palayoor S; Matlin SA; Hait WN; Cowan KH
Mol Pharmacol; 1990 Jun; 37(6):840-7. PubMed ID: 2193225
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
Ogretmen B; McCauley MD; Safa AR
Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006
[TBL] [Abstract][Full Text] [Related]
14. Relationship of multidrug resistance to rhodamine-123 selectivity between carcinoma and normal epithelial cells: taxol and vinblastine modulate drug efflux.
Brouty-Boyé D; Kolonias D; Wu CJ; Savaraj N; Lampidis TJ
Cancer Res; 1995 Apr; 55(8):1633-8. PubMed ID: 7712466
[TBL] [Abstract][Full Text] [Related]
15. Estradiol induction of rhodamine 123 efflux and the multidrug resistance pump in rat pituitary tumor cells.
Jancis EM; Carbone R; Loechner KJ; Dannies PS
Mol Pharmacol; 1993 Jan; 43(1):51-6. PubMed ID: 8423769
[TBL] [Abstract][Full Text] [Related]
16. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of the antineoplastic drug lonidamine: 31P and 13C nuclear magnetic resonance studies.
Ben-Horin H; Tassini M; Vivi A; Navon G; Kaplan O
Cancer Res; 1995 Jul; 55(13):2814-21. PubMed ID: 7796408
[TBL] [Abstract][Full Text] [Related]
18. Effect of the antitumor drug lonidamine on glucose metabolism of adriamycin-sensitive and -resistant human breast cancer cells.
Fanciulli M; Valentini A; Bruno T; Citro G; Zupi G; Floridi A
Oncol Res; 1996; 8(3):111-20. PubMed ID: 8823807
[TBL] [Abstract][Full Text] [Related]
19. Differences in phosphate metabolite levels in drug-sensitive and -resistant human breast cancer cell lines determined by 31P magnetic resonance spectroscopy.
Cohen JS; Lyon RC; Chen C; Faustino PJ; Batist G; Shoemaker M; Rubalcaba E; Cowan KH
Cancer Res; 1986 Aug; 46(8):4087-90. PubMed ID: 3731076
[TBL] [Abstract][Full Text] [Related]
20. Human breast cancer MCF-7 cell line contains inherently drug-resistant subclones with distinct genotypic and phenotypic features.
Devarajan E; Chen J; Multani AS; Pathak S; Sahin AA; Mehta K
Int J Oncol; 2002 May; 20(5):913-20. PubMed ID: 11956583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
